• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《COVID-19患者管理的基础重症护理:印度重症护理医学会立场文件,第二部分》

Basic Critical Care for Management of COVID-19 Patients: Position Paper of the Indian Society of Critical Care Medicine, Part II.

作者信息

Juneja Deven, Savio Raymond D, Srinivasan Shrikanth, Pandit Rahul A, Ramasubban Suresh, Reddy Pavan K, Singh Manoj K, Gopal Palepu Bn, Chaudhry Dhruva, Govil Deepak, Dixit Subhal B, Samavedam Srinivas

机构信息

Institute of Critical Care Medicine, Max Super Speciality Hospital, New Delhi, India.

Department of Critical Care Medicine, Apollo Hospitals, Chennai, Tamil Nadu, India.

出版信息

Indian J Crit Care Med. 2020 Nov;24(Suppl 5):S254-S262. doi: 10.5005/jp-journals-10071-23593.

DOI:10.5005/jp-journals-10071-23593
PMID:33354049
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7724927/
Abstract

In a resource-limited country like India, rationing of scarce critical care resources might be required to ensure appropriate delivery of care to the critically ill patients suffering from COVID-19 infection. Most of these patients require critical care support because of respiratory failure or presence of multiorgan dysfunction syndrome. As there is no pharmacological therapy available, respiratory support in the form of supplemental oxygen, noninvasive ventilation, and invasive mechanical ventilation remains mainstay of care in intensive care units. As there is still dearth of direct evidence, most of the data are extrapolated from the experience gained from the management of general critical care patients. Juneja D, Savio RD, Srinivasan S, Pandit RA, Ramasubban S, Reddy PK, Basic Critical Care for Management of COVID-19 Patients: Position Paper of the Indian Society of Critical Care Medicine, Part II. Indian J Crit Care Med 2020;24(Suppl 5):S254-S262.

摘要

在像印度这样资源有限的国家,可能需要对稀缺的重症监护资源进行配给,以确保为患有新冠病毒感染的重症患者提供适当的护理。这些患者中的大多数因呼吸衰竭或存在多器官功能障碍综合征而需要重症监护支持。由于没有可用的药物治疗方法,以补充氧气、无创通气和有创机械通气形式的呼吸支持仍然是重症监护病房护理的主要手段。由于仍然缺乏直接证据,大多数数据是从一般重症监护患者管理经验中推断出来的。Juneja D、Savio RD、Srinivasan S、Pandit RA、Ramasubban S、Reddy PK,《新冠病毒感染患者管理的基础重症监护:印度重症监护医学学会立场文件,第二部分》。《印度重症监护医学杂志》2020年;24(增刊5):S254 - S262。

相似文献

1
Basic Critical Care for Management of COVID-19 Patients: Position Paper of the Indian Society of Critical Care Medicine, Part II.《COVID-19患者管理的基础重症护理:印度重症护理医学会立场文件,第二部分》
Indian J Crit Care Med. 2020 Nov;24(Suppl 5):S254-S262. doi: 10.5005/jp-journals-10071-23593.
2
Basic Critical Care for Management of COVID-19 Patients: Position Paper of Indian Society of Critical Care Medicine, Part-I.《COVID-19患者管理的基础重症护理:印度重症护理医学会立场文件,第一部分》
Indian J Crit Care Med. 2020 Nov;24(Suppl 5):S244-S253. doi: 10.5005/jp-journals-10071-23601.
3
Critical Care for COVID-19 Affected Patients: Updated Position Statement of the Indian Society of Critical Care Medicine.新冠疫情相关患者的重症监护:印度重症监护医学学会的最新立场声明
Indian J Crit Care Med. 2020 Nov;24(Suppl 5):S225-S230. doi: 10.5005/jp-journals-10071-23621.
4
ISCCM Guidelines for Hemodynamic Monitoring in the Critically Ill.重症医学会危重病患者血流动力学监测指南
Indian J Crit Care Med. 2022 Oct;26(Suppl 2):S66-S76. doi: 10.5005/jp-journals-10071-24301.
5
Airway Management and Related Procedures in Critically Ill COVID-19 Patients: Position Statement of the Indian Society of Critical Care Medicine.危重症COVID-19患者的气道管理及相关操作:印度重症医学学会立场声明
Indian J Crit Care Med. 2020 Aug;24(8):630-642. doi: 10.5005/jp-journals-10071-23471.
6
Infection Prevention and Control for ICU during COVID-19 Pandemic: Position Paper of the Indian Society of Critical Care Medicine.2019冠状病毒病大流行期间重症监护病房的感染预防与控制:印度重症监护医学学会立场文件
Indian J Crit Care Med. 2020 Nov;24(Suppl 5):S280-S289. doi: 10.5005/jp-journals-10071-23607.
7
Critical Care for COVID-19 Affected Patients: Position Statement of the Indian Society of Critical Care Medicine.新型冠状病毒肺炎(COVID-19)感染患者的重症监护:印度重症监护医学学会立场声明
Indian J Crit Care Med. 2020 Apr;24(4):222-241. doi: 10.5005/jp-journals-10071-23395.
8
Respiratory Care for Severe COVID-19.重症新型冠状病毒肺炎的呼吸治疗
Indian J Crit Care Med. 2020 Jul;24(7):493-495. doi: 10.5005/jp-journals-10071-23509.
9
The Indian Society of Critical Care Medicine Position Statement on the Management of Sepsis in Resource-limited Settings.印度重症监护医学学会关于资源有限环境下脓毒症管理的立场声明。
Indian J Crit Care Med. 2024 Aug;28(Suppl 2):S4-S19. doi: 10.5005/jp-journals-10071-24682. Epub 2024 Aug 10.
10
Procedures in COVID-19 Patients: Part-I.新冠肺炎患者的诊疗程序:第一部分。
Indian J Crit Care Med. 2020 Nov;24(Suppl 5):S263-S271. doi: 10.5005/jp-journals-10071-23597.

引用本文的文献

1
RT-PCR Result of SARS-CoV-2 Viral RNA in Cadavers and Viral Transmission Risk to Handlers.尸体中新型冠状病毒2型病毒RNA的逆转录聚合酶链反应结果及对处理人员的病毒传播风险
Indian J Crit Care Med. 2024 Jun;28(6):614-616. doi: 10.5005/jp-journals-10071-24730.
2
Pathological Lung Patterns of COVID-19 and its Clinical Correlation to Disease Severity.新型冠状病毒肺炎的肺部病理模式及其与疾病严重程度的临床相关性。
Indian J Crit Care Med. 2022 Dec;26(12):1285-1292. doi: 10.5005/jp-journals-10071-24364.

本文引用的文献

1
Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS.COVID-19 引起的 ARDS 的临床特征、通气管理和预后与其他原因引起的 ARDS 相似。
Intensive Care Med. 2020 Dec;46(12):2200-2211. doi: 10.1007/s00134-020-06192-2. Epub 2020 Jul 29.
2
C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis.C 反应蛋白、降钙素原、D-二聚体和铁蛋白在严重 2019 冠状病毒病中的meta 分析。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620937175. doi: 10.1177/1753466620937175.
3
Emergence of institutional antithrombotic protocols for coronavirus 2019.2019冠状病毒病机构性抗血栓形成方案的出现。
Res Pract Thromb Haemost. 2020 Jun 12;4(4):510-517. doi: 10.1002/rth2.12358. eCollection 2020 May.
4
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report.新型冠状病毒肺炎患者静脉血栓栓塞症的预防、诊断和治疗:CHEST 指南和专家报告。
Chest. 2020 Sep;158(3):1143-1163. doi: 10.1016/j.chest.2020.05.559. Epub 2020 Jun 2.
5
Co-infections in people with COVID-19: a systematic review and meta-analysis.COVID-19 患者合并感染:系统评价和荟萃分析。
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
6
Heparin resistance in COVID-19 patients in the intensive care unit.COVID-19 患者在重症监护病房中肝素耐药。
J Thromb Thrombolysis. 2020 Aug;50(2):287-291. doi: 10.1007/s11239-020-02145-0.
7
Plasma CRP level is positively associated with the severity of COVID-19.血浆 CRP 水平与 COVID-19 的严重程度呈正相关。
Ann Clin Microbiol Antimicrob. 2020 May 15;19(1):18. doi: 10.1186/s12941-020-00362-2.
8
Recruitability and effect of PEEP in SARS-Cov-2-associated acute respiratory distress syndrome.呼气末正压通气在新型冠状病毒肺炎相关急性呼吸窘迫综合征中的可复张性及效果
Ann Intensive Care. 2020 May 12;10(1):55. doi: 10.1186/s13613-020-00675-7.
9
Incidence of venous thromboembolism in hospitalized patients with COVID-19.COVID-19 住院患者静脉血栓栓塞症的发生率。
J Thromb Haemost. 2020 Aug;18(8):1995-2002. doi: 10.1111/jth.14888. Epub 2020 Jul 27.
10
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高:一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.